{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:50:28Z","timestamp":1766181028752},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.nucmedbio.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T19:51:57Z","timestamp":1508788317000},"page":"12-19","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates"],"prefix":"10.1016","volume":"57","author":[{"given":"Vladimir","family":"Stepanov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Hasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhide","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0005","first-page":"458","article-title":"PDE10A inhibitors: an assessment of the current CNS drug discovery landscape","volume":"12","author":"Chappie","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(03)02754-9","article-title":"Immunohistochemical localization of PDE10A in the rat brain","volume":"985","author":"Seeger","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0015","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1021\/jm3004976","article-title":"Current landscape of phosphodiesterase 10A (PDE10A) inhibition","volume":"55","author":"Chappie","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/138161211795049624","article-title":"PDE10A inhibitors: novel therapeutic drugs for schizophrenia","volume":"17","author":"Kehler","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0025","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1038\/npp.2016.20","article-title":"TAK-063, a PDE10A inhibitor with balanced activation of direct and indirect pathways, provides potent antipsychotic-like effects in multiple paradigms","volume":"41","author":"Suzuki","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/jpet.116.237388","article-title":"TAK-063, a novel phosphodiesterase 10A inhibitor, protects from striatal neurodegeneration and ameliorates behavioral deficits in the R6\/2 mouse model of Huntington\u2019s disease","volume":"360","author":"Harada","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia","volume":"325","author":"Schmidt","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","article-title":"Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis","volume":"51","author":"Siuciak","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0045","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2174\/1381612013396871","article-title":"PET studies with carbon-11 radioligands in neuropsychopharmacological drug development","volume":"7","author":"Halldin","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nucmedbio.2009.12.012","article-title":"Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation","volume":"37","author":"Tu","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0055","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.bmc.2011.01.032","article-title":"Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain","volume":"19","author":"Tu","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroimage.2013.04.123","article-title":"Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A","volume":"82","author":"Celen","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0065","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2967\/jnumed.114.140178","article-title":"Discovery and development of 11C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain","volume":"55","author":"Kehler","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nucmedbio.2014.01.007","article-title":"Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates","volume":"41","author":"Hwang","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0075","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.bmc.2014.03.028","article-title":"Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate","volume":"22","author":"Fan","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jlcr.3284","article-title":"Development of a series of novel carbon-11 labeled PDE10A inhibitors","volume":"58","author":"Stepanov","year":"2015","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nucmedbio.2014.09.005","article-title":"Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A","volume":"42","author":"Harada","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/syn.21896","article-title":"Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11C]T-773 in nonhuman primates","volume":"70","author":"Takano","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0095","author":"Taniguchi"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1124\/jpet.109.155994","article-title":"Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia","volume":"331","author":"Grauer","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0105","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1021\/jm900521k","article-title":"Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia","volume":"52","author":"Verhoest","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0969-8043(02)00123-9","article-title":"[18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine","volume":"57","author":"Iwata","year":"2002","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2191-219X-1-33","article-title":"Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET","volume":"1","author":"Jahan","year":"2011","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/syn.20031","article-title":"PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain","volume":"53","author":"Schou","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2967\/jnumed.109.067074","article-title":"Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands","volume":"51","author":"Terry","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1020689314452","article-title":"Optimization of automated synthesis of 2-[18F] Fluoro-2-deoxy-D-glucose involving base hydrolysis","volume":"44","author":"Gomzina","year":"2002","journal-title":"Radiochemistry"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ilar.38.1.41","article-title":"Special report: the 1996 guide for the care and use of laboratory animals","volume":"38","author":"Clark","year":"1997","journal-title":"ILAR J"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02245691","article-title":"PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor","volume":"113","author":"Karlsson","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpba.2014.05.024","article-title":"Determination of plasma protein binding of positron emission tomography radioligands by high-performance frontal analysis","volume":"98","author":"Amini","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"3","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2017.10.004_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroimage.2016.06.047","article-title":"A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor","volume":"141","author":"Takano","year":"2016","journal-title":"Neuroimage"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117302652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117302652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T15:02:34Z","timestamp":1535295754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805117302652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":31,"alternative-id":["S0969805117302652"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.10.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}